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UNIT A13.2Deep Vein Thrombosis Detection
Although magnetic resonance angiography (MRA) is a robust and noninvasive technique
for evaluating the vascular system with respect to deep venous thrombosis (DVT) of the
lower extremities, there are several competing modalities, which primarily involve duplex
sonography and currently, delayed contrast enhanced spiral computed tomography (CT)
following a pulmonary CT angiography study. At the authors’ institution, patients with
suspected pulmonary embolisms and lower extremity DVTs are primarily worked up with
lower extremity duplex sonography and spiral (helical) computed tomography of the
pulmonary vasculature. Lower extremity MR venography (MRV) is performed primarily
in patients where a pelvic source of emboli is suspected and if a duplex sonogram was
not performed. In these patients, the groin is evaluated down to the proximal calf and this
is supplemented with imaging of the pelvis.
In patients where the pulmonary MRA study, when performed, is equivocal or unremark-
able, a lower extremity MRV study is also performed. Multi-station imaging to include
the thorax, pelvis, and lower extremities in a patient with suspected pulmonary embolus
is certainly time consuming since the patient, including body phased array coils, needs
to be repositioned at each respective region of interest. These protocols may be as long
as 2 hr, which is prohibitively long in this patient population. Fortunately, with the
development of stepping MRI tables, the entire multi-station examination to include the
chest, pelvis, and lower extremities can be performed much faster. At the authors’
institution, a manually retrofitted stepping MRI table known as the stepping kinematic
imaging platform (SKIP, Magnetic Moments) is employed. The SKIP device allows the
user to employ the existing body phased array coil for improved spatial resolution and
signal-to-noise as compared to a quadrature body coil.
Venous imaging within the pelvis and lower extremities is primarily performed with
transverse 2-D TOF (time of flight) techniques employing an arterial traveling saturation
band. Although 3-D contrast enhanced MRA techniques utilizing extracellular MRI
contrast agents such as Omniscan, ProHance, or Magnevist can be employed, the venous
signal is, frequently, not as robust as that on 2-D TOF sequences. Lower venous signal
on 3-D contrast enhanced MRA is due to the filtering effect at the capillary bed whereby
50% of the contrast concentration is reduced due to the first pass. In the future, however,
implementation of blood-pool agents, such as MS-325 (EPIX Medical) will likely be the
preferred agent for evaluating deep venous thrombosis. Finally, MRV within the pelvis
can be supplemented with T1- and T2-weighted sequences, when the MRV is abnormal,
for differentiating intrinsic from extrinsic disease and in characterizing extrinsic pathol-
ogy.
BASIC
PROTOCOL 1
IMAGING THE PELVIC AND LOWER EXTREMITY VEINS
The sequence described herein is based on the authors’ experience on a Siemens 1.5T
Vision scanner, however, the protocol is likely equally applicable to machines from other
manufacturers. Currently, this technique is the protocol of choice since contrast enhanced
3-D MRA techniques employing a blood-pool agent have not yet been tested and have
not been FDA (Food and Drug Administration)-approved.
In patients where pulmonary MRA is performed, this protocol is performed after the
pulmonary examination has been completed. If the stepping kinematic imaging platform
(SKIP) is utilized, the patient is simply manually repositioned to the pelvic station. If a
stepping table is not available, the patient is taken out of the magnet bore isocenter and
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the phased array coil and patient is repositioned by centering the coil at the mid-point
between the umbilicus and symphysis pubis. The equipment parameters are listed in Table
A13.2.1.
The entire examination should take ∼40 min.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Materials
Normal saline (0.9% NaCl), sterile
Extracellular contrast agents (e.g., Magnevist, Omniscan, or ProHance)
Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no contraindications such
as cardiac pacemakers or other implants containing ferromagnetic materials. Also,
be sure to find out if the patient has any health conditions that may require the presence
of special emergency equipment during the scanning procedure, or necessitate any
other precautions.
Generally, standard screening forms (APPENDIX 1) are used for all patients scanned in a
magnetic resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for a discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
forms.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
Table A13.2.1 Hardware Requirements for Deep Vein Thrombosis
Detection
Coil type Body phased array coil preferred over
quadrature body coil
Maximum gradient coil
strength
25 mT/m (or whatever the system permits)
Cardiac triggering No
Peripheral vital sign
monitoring
Optional (blood pressure, heart rate, and
peripheral O2 saturation)
Respiratory gating No
Respirator If required by patient
Oxygen Usually administered in these patients
(2-3 liters/min by nasal cannula)
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5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results, the patient should not talk and should avoid other movement,
during each scan—i.e., as long as the banging sounds continue.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
6. Establish an i.v. line in the antecubital fossa employing a 20-G angiocatheter needle.
Connect the angiocatheter to the saline at a rate to keep the vein open.
Preferably, however, it is connected to a power injector for more reproducible delivery of
contrast agent. At the authors’ institution, a MedRad power injector (MedRad) is used.
7. Have the patient lie down on the table, with feet first, over the posterior phased array
coil.
8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Use the centering light to position the patient (halfway point between umbilicus and
symphysis pubis) and put him or her into the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative.
If the patient requires sedation, peripheral monitoring (blood pressure, heart rate, periph-
eral O2 saturation, and CO2 capnometry) is required.
Sequence 1: Rapid three-plane positioning scouts
11. Run the system’s pilot scan to insure the correct location of the patient’s pelvis
according to the imaging parameters given in Table A13.2.2.
Three orthogonal planes are obtained.
These positioning scouts are performed to validate the patient’s position and to provide
anatomical landmarks for subsequent sequences.
Sequence 2: 2-D time-of-flight
12. Prescribe five imaging stacks in an overlapping fashion per region of interest to cover
a distance of 35.0 cm. Run sequence 2 according to Table A13.2.3.
NOTE: Table A13.2.3 only covers 70 mm.
13. After obtaining five stacks at the pelvic station, reposition the patient to the mid-thigh
level for imaging the superficial femoral veins down to the popliteal vein. Repeat step
12.
Each imaging stack requires 2 min of acquisition time with ∼1 to 2 min of reconstruction
time. Typically, the vasculature is covered down to the popliteal trifurcation, since at most
institutions, deep venous thrombosis within the calf is typically not sought for since it is
not treated.
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Table A13.2.2 Imaging Parameters for Sequence 1 (Localizers)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse, sagittal, and coronal
Central slice or volume center Laser light centered at a point halfway
between umbilicus and symphisis pubis
Echo time (TE) 6.0 msec
Repeat time (TR) 15.0 msec
Flip angle (FA) 30°
Fields of view (FOVx, FOVy) 450 mm, 450 mm
Resolution (∆x, ∆y) 1.76 mm, 3.52 mm
Number of data points collected (Nx, Ny) 256a, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 3
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Scan time 10 sec
aOversampling.
Table A13.2.3 Imaging Parameters for Lower Extremity 2-D TOF MRV
Patient positioning Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center The cranial initial 2-D slab is
positioned at a point just above the
iliac crest to cover the lower inferior
vena cava. The lower stack typically
covers a point just below the inguinal
region.
Echo time (TE) 7.0 msec
Repeat time (TR) 608 msec
Flip angle (FA) 70°
Fields of view (FOVx, FOVy) 350 mma, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.31 mm
Number of data points collected (Nx, Ny) 256, 114
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 3 mm
Number of slices 32
Slice gap −0.81 mm (−27%)
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses Traveling superior saturation pulse for
arterial saturation
Scan time 1 min, 57 sec
aOversampling.
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Data processing and viewing for sequence 2
14. Use these five stacks acquired at each region of interest to obtain maximum intensity
projection images. Use the source data to review for filling defects (see UNIT A13.1,
Anticipated Results).
Sequence 3: Bolus test assessment
15. Review the rapid three-plane positioning scouts and position the transverse bolus test
slice at the midpoint (iliac arteries) within the region of interest. Inject 2 ml contrast
agent at a rate of 1.5 ml/sec followed by a saline flush of 15 to 20 ml at a similar rate
of 1.5 ml/sec.
16. Perform a transverse bolus test assessment study by running sequence 3 according
to imaging parameters in Table A13.2.4. Review the image data and note the time
that it takes for the contrast agent to arrive at the imaging slice position. This is the
bolus arrival time that can be used as the scan delay time.
Sequence 4: 3-D contrast-enhanced MRV
The pilot scouts (sequence 1) are reviewed and the coronal 3-D contrast enhanced MRV
sequence is appropriately placed to evaluate the course of the common and external iliac,
common femoral and superficial femoral and finally, popliteal veins. Without a stepping
MRI table, the three regions of interest (pelvis, thighs, and legs) are evaluated with three
separate injections, however, with an MRI stepping table (see Basic Protocol 2), two
regions of interest (pelvis and thighs), can be evaluated with just one contrast agent
injection utilizing the bolus chase protocol. At this time, however, implementation of 3-D
contrast MRV with extracellular MRV contrast agents is not promoted due to the lower
vascular-to-background contrast of the venous signal. This protocol, however, can be
employed as a rapid screening procedure for evaluating the presence or absence of gross
abnormalities. In the future, it will likely be replaced employing the same sequence but
with a blood pool agent such as MS-325, whereby arterial pass imaging is followed by
Table A13.2.4 Imaging Parameters for Test Bolus Assessment
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slice centered at midpoint within the
first region of interest
Echo time (TE) 2.4 msec
Repeat time (TR) 5.8 msec
Inversion time (TI) 300 msec
Flip angle (FA) 8°
Fields of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 1
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Number of repetitions 60
Swap read and phase encoding No
Saturation pulses No
Scan time 60 seca
aEach acquisition time is 1 sec, and the total scan time is 60 sec.
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steady state image acquisition to obtain the venous anatomy. The arterial first pass
anatomy is then used as a mask for subtracting from the steady state image acquisition
data to yield venous-only data. The imaging parameters are similar to those described for
pulmonary MRA (UNIT A13.1) but with slight modifications as listed below in Table A13.2.5.
Without a stepping table, each region of interest is imaged with two measurements:the
first measurement will display the arterial anatomy; the second, the venous anatomy
during steady state. A time delay between two measurements is ∼60 sec. Subsequently,
the patient and imaging coils are repositioned to the next region of interest (e.g., thighs)
and the protocol is repeated as in the pelvis.
17. Leaving the patient in the magnet, inject the contrast agent, flush the line with 20 ml
saline, wait for the bolus arrival time, and then run sequence 4 according to Table
A13.2.5.
A dose of 0.1 mmol/kg of contrast agent is usually given.
18. Pull the patient out of the magnet, reposition the coil at the thigh, center the patient
into the magnet, and repeat sequences 1, 3, and 4 (steps 11, 15 to 17).
19. Pull the patient out of the magnet, reposition the coil at the legs, center the patient
into the magnet, and repeat sequences 1, 3, and 4 (steps 11, 15 to 17).
Table A13.2.5 Imaging Parameters for 3-D Contrast Enhanced MRV of Lower
Extremities and Pelvis
Patient position Supine
Scan type 3-D gradient echo with sync
interpolation
Imaging plane (orientation) Coronal
Central slice or volume center Coronal slab is centered at the iliac,
femoral and popliteal vessels
Echo time (TE) As short as possible (currently, 1.8
msec)
Receiver bandwidth (RBW) 390 Hz
Repeat time (TR) 4.6 msec
Flip angle (FA) 25°
Fields of view (FOVx, FOVy) 450 mm, 338 mm
Resolution (∆x, ∆y) 0.88 mm, 1.72 mm
Number of data points collected (Nx, Ny) 512, 196
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 4.55–5.45 mm
Number of slices 22 (interpolated to 44)
Slab thickness 100–120 mm
Slice gap 0 mm
Number of acquisitions (Nacq) 1
Number of repetitions 2
Swap read and phase encoding No
Scan timea 21 sec
aThe time delay between two measurements is 60 sec and the total scan time is 102 sec.
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BASIC
PROTOCOL 2
IMAGING THE PELVIC AND LOWER EXTREMITY VEINS WITH A
STEPPING TABLE
If a stepping table is available, sequence 4 can be run differently. During a time difference
of 5 sec, the table is manually repositioned from the first region of interest (pelvis) to the
second region of interest (thigh) and the bolus is chased to image the arterial anatomy at
the second region of interest. After this, a 30- to 45-sec delay is employed followed by
two additional measurements, one is at the second region of interest and the other is at
the first region of interest. The time difference between the last two measurements is also
5 sec to allow for the table stepping to be repositioned.
Set up patient and equipment
1. Repeat Basic Protocol 1, steps 1 to 11 and 15 to 17.
2. Repeat Basic Protocol 1, step 17, with the number of repetitions set to 4 in Table
A13.2.5.
3. Reposition the stepping table from the pelvis to the thigh area by moving the table
by one field of view.
This is done in 5 sec so it is still at the arterial phase.
4. Obtain images according to Table A13.2.5.
The scan time will be 21 sec in Table A13.2.5.
5. Wait for 30 to 45 sec and repeat step 4.
This is the venous phase at the thigh.
6. Reverse step 3, i.e., reposition the stepping table from the thigh area to the pelvis area
by one field of view.
This is done in 5 sec.
7. Repeat step 4.
COMMENTARY
Background Information
Primary indications for performing venous
MR angiography include: (1) detection and
exclusion of deep venous thrombosis, (2)
saphenous venous mapping to determine its
suitability in coronary bypass, and (3) monitor-
ing post-thrombotic changes. Current develop-
ments in magnetic resonance imaging, espe-
cially time-of-flight (TOF) techniques and con-
trast enhanced MR venography have been
successful in the study of venous pathology
noninvasively without the need for catheter-
based angiography.
The imaging techniques are broadly classi-
fied into two main categories; (1) bright blood
technique and (2) black blood technique. Bright
blood signal can be either due to flow-related
enhancement such as in TOF techniques or
flow-induced phase shifts such as in phase
contrast techniques. The black blood tech-
nique, on the other hand, is based on nulling
the flow signal by using gradients to induce
phase shifts. Among the available TOF tech-
niques, a non-ECG triggered sequential 2-D
TOF with a traveling saturation band is well
suited for venous MRA in the pelvis and lower
extremity. A traveling saturation band is placed
superior to the slice so that arterial signal is
saturated. With a sequential mode of data ac-
quisition, the slice acquisition follows the
course of the flow providing uniform signal
across each slice.
In the pelvic region, 2-D TOF techniques
have been very accurate when compared to
conventional venography (Evans et al., 1993;
Carpenter et al., 1993). Furthermore, it is robust
and easy to implement. However, deep small
veins are often missed or not clearly visualized
due to insufficient inflow effects. Under these
circumstances, subtraction techniques have
been useful by eliminating background signal
to improve small vessel signal (Lebowitz et al.,
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1997). Another disadvantage with the 2-D TOF
is the loss of signal due to in-plane saturation
when vessels course parallel to the imaging
plane. Contrast enhanced angiography, on the
other hand, relies on reducing T1-relaxation,
consequently, increasing the blood signal. The
reduction in T1 that results in signal enhance-
ment is independent of flow direction and,
hence, is independent of acquisition plane ori-
entation. Recently, blood pool agents have been
used to image the pelvis and lower extremities
(Saeed et al., 1998).
Critical Parameters and
Troubleshooting
Lower extremity MRV imaging is generally
tolerated by patients as it does not require
patients holding their breath during the scan.
A B
C
Figure A13.2.1 Acute nonocclusive DVT. The MIP image (A) from a 2-D TOF MRV study shows a low intensity
defect involving the left common iliac vein. This is a pitfall of extrinsic compression of the vein from the overlying
common iliac artery as demonstrated on the transverse 2-D TOF source data (B) at that location. A nonocclusive
low signal filling defect consistent with acute thrombus is seen in the left proximal superficial femoral vein. This is
best visualized by reviewing the transverse 2-D TOF source data (C) and can be overlooked if only the MIP images
are viewed.
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Figure A13.2.2 Chronic lower extremity DVT. MIP images from the proximal (A), mid (B), and distal (C) stations of a
2-D TOF MRV study are shown. The stepping kinematic imaging platform (SKIP) was employed for rapid repositioning
of the patient relative to the phased array coils when proceeding from one station to the next. Occlusive disease with
collateral veins are shown at all stations.
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Figure A13.2.3 Pulmonary 3-D contrast enhanced MRA followed by venous steady state imaging. The coronal
contrast enhanced (Omniscan, Amersham Health) 3-D MRA MIP image of the proximal station to include the pulmonary
vessels is shown (A) followed by the pelvic and thigh arterial anatomy (B). A single peripheral i.v. injection of contrast
was employed along with stepping kinematic imaging platform (SKIP) for MRI table stepping. After stepping the table
back to the proximal station, 30 sec later, a steady state image acquisition was made at both imaging stations again.
The arterial phase data from (A) and (B) were used as a mask and subtracted from the steady state data. The MIP
images of the subtracted data yield only venous anatomy at both stations (C, D).
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Short TR gradient echo sequences have been
widely applied to clinical MRV.
Saturation Artifacts
Magnetic resonance angiography without
the use of a contrast agent works on the princi-
ple of signal improvement due to inflow of fresh
unsaturated spins into the imaging volume. The
conventional 2-D TOF approach, without con-
trast and with a traveling saturation band
(placed superiorly), has a problem associated
with motion and in-plane saturation. In areas
where vessels become tortuous and parallel to
the plane of acquisition (such as the common
iliac area), blood spins will be saturated due to
repeated application of RF pulses. The in-plane
saturation is a well known phenomenon and
causes severe loss of signal during imaging
when vessels course parallel to the excitation
plane and is routinely seen in noncontrast en-
hanced methods. Contrast enhanced 3-D MRV
techniques, on the other hand, do improve ves-
sel visualization due to improved relaxivity of
blood spins. Actual application of the sequence
presented in this unit may require some modi-
fications depending on the region of interest
covered.
Anticipated Results
Nonocclusive thrombus on 2-D TOF MRV
presents as a low signal intensity-filling defect.
This frequently is detected on source data and
can be frequently missed if only maximum
intensity projections (MIPs) are reviewed. Oc-
clusive thrombus with collaterals, however, is
better appreciated when reviewing the MIPs.
Examples of nonocclusive and occlusive
thromboses are depicted with 2-D TOF MRV
(Figs. A13.2.1 and A13.2.2). Arterial first-pass
3-D contrast enhanced pulmonary and lower
extremity imaging followed by steady state
imaging to demonstrate the lower extremity
venous anatomy is shown in Fig. A13.2.3.
Blood pool contrast enhanced MRV
The availability of blood pool agents in the
future is likely to expand beyond the current
experimental use of MS-325. Similar protocols
that are employed above with extracellular con-
trast agents can be applied for more robust
imaging of the veins in this patient population.
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